IL-12 as an immunopotentiator in leishmaniasis

IL-12 作为利什曼病的免疫增强剂

• 批准号: 6877148
• 负责人: PHILLIP SCOTT
• 金额: $ 39.63万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-09-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6877148
• 关键词: Leishmania major; RNase protection assay; T cell receptor; T lymphocyte; antigen antibody reaction; antigen presentation; cell sorting; cellular immunity; dendritic cells; enzyme linked immunosorbent assay; flow cytometry; genetically modified animals; helper T lymphocyte; immunocytochemistry; immunologic memory; immunoregulation; interleukin 12; intracellular parasitism; laboratory mouse; leishmaniasis; leukocyte activation /transformation; natural killer cells; polymerase chain reaction; receptor expression

DESCRIPTION (provided by the applicant): Experimental Leishmania major infections in mice have been used extensively to understand how cell-mediated immunity (CMI) develops, and to specifically define the factors that dictate whether a Thl or Th2 response is observed after activation of T cells. Such studies have clearly shown an important role for IL-12 in the development of resistance and a Thl response. However, despite a great increase in our knowledge of the events that are associated with the development of Thl responses, little is understood about the rules that govern the maintenance of CMI. Our laboratory has recently shown that IL-12 is required not only to initiate Thl cell development, but also to maintain this response. This proposal seeks to determine how IL-12 participates in maintaining CMI, and in so doing will more broadly investigate how immunologic memory works in L. major healed mice. Our specific aims address the three critical components for CMI: memory T cell function (Aim 1), the antigen-in this case the role of parasite persistence (Aim 2), and the accessory cells-specifically dendritic cells-that both present antigen and influence the nature of the T cells that develop (Aim 3). The working hypothesis of this proposal is that CMI requires the constant renewal of the Thl population from a non-polarized pool of T cells. To test this hypothesis a series of adoptive transfer experiments are proposed, both with conventional T cells, as well as TCR transgenic T cells recognizing a leishmanial antigen. The donor cells will be followed in the recipient mice to assess their trafficking patterns, cytokine production and life span. An analysis of the role of parasite persistence will use a L. major (dhfr-ts-) thymidine auxotroph that infects mice, but fails to survive. Finally, the role of antigen presentation will be assessed by characterizing the dendritic cell response associated with resistance. Preliminary studies from this laboratory demonstrated that CD40-CD40L interactions are not required for maintenance of immunity, and in this aim, the compensatory role of TRANCE will be tested. Overall, these experiments should provide a clear picture of the dynamic interactions between T cells, dendritic cells and persisting parasites that are required to maintain cell-mediated immunity.

描述（由申请人提供）：小鼠中的实验性利什曼原虫主要感染已被广泛用于了解细胞介导的免疫（CMI）如何发展，并具体定义决定T细胞活化后是否观察到Th 1或Th 2应答的因素。这些研究已经清楚地显示IL-12在抗性和Thl应答的发展中的重要作用。然而，尽管我们对与Thl应答的发展相关的事件的知识有了很大的增加，但对管理CMI维持的规则却知之甚少。我们的实验室最近表明，IL-12不仅是启动Thl细胞发育所必需的，而且是维持这种应答所必需的。本研究试图确定IL-12是如何参与维持CMI的，从而更广泛地研究免疫记忆在L.治愈的老鼠我们的具体目标是解决CMI的三个关键组成部分：记忆T细胞功能（目标1），抗原-在这种情况下寄生虫持久性的作用（目标2），和辅助细胞-特别是树突状细胞-既呈递抗原，又影响发育的T细胞的性质（目标3）。该提议的工作假设是CMI需要来自非极化T细胞库的Thl群体的不断更新。为了验证这一假设，提出了一系列过继转移实验，既有传统的T细胞，也有识别利什曼原虫抗原的TCR转基因T细胞。将在受体小鼠中跟踪供体细胞，以评估其运输模式、细胞因子产生和寿命。寄生虫持续性的作用分析将使用L。感染小鼠但不能存活的主要（dhfr-ts-）胸苷营养缺陷型。最后，抗原呈递的作用将通过表征与抗性相关的树突状细胞应答来评估。该实验室的初步研究表明，维持免疫力不需要CD 40-CD 40 L相互作用，为此，将检测TRANCE的代偿作用。总的来说，这些实验应该提供一个清晰的图片之间的动态相互作用的T细胞，树突状细胞和持久的寄生虫，需要维持细胞介导的免疫力。